Overview


According to FutureWise analysis the market for Nanobodies in 2023 is US$ 0.36 billion, and is expected to reach US$ 2.05 billion by 2031 at a CAGR of 24.32%.

Nanobodies are modified antibodies with a single antigen-binding domain created by heavy chains. Due to their size and single-chain nature, these antibodies can be designed and are useful for a wide range of applications in research, pharmaceutical development, and medical diagnosis. Nanobodies, have a variety of special qualities, such as small size, good solubility, enhanced stability, rapid blood clearance, and deep tissue penetration. Nanobodies are therefore developing into a promising diagnostic and therapeutic tool. As imaging tracers, nanobodies enable early high-quality image acquisition, complete assessment of the situation, and then individualized precision therapy. By delivering lesion-specific medications and effector domains to the site of the lesion, nanobodies as therapeutic agents provide targeted therapy, enhancing the specificity and effectiveness of the treatment.

Single domain antibodies known as nanobodies are derived from heavy-chain antibodies in mammals and have special characteristics such as nanoscale size, robust structure, stable and soluble behaviour in aqueous solution, reversible protein folding, high affinity and specificity for only one cognate target, among others. Applications for nanobodies vary from fundamental research to medical therapeutics. Nanobodies, which are used as affinity capture reagents because of their tiny size and single domain chain, have a greater binding surface and less nonspecific background binding. Additionally, nanobodies can be used to treat cancer and other diseases by obstructing ligand-receptor interactions, such as blocking anti-TNF-a to treat arthritis or antagonizing anti-von Willebrand factor to avoid thrombosis. To track antigen activity, nanobodies can also be produced inside cells and combined with a fluorescent protein. The ability of nanobodies to anchor proteins is advantageous, which is crucial when a protein is crystallizing. Due to their capacity to bind proteins in a specific conformation and stabilize flexible domains, nanobodies are thus utilized in a variety of protein crystallization studies.

FutureWise Market Research has published a report that provides an insightful analysis of Nanobodies market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the Nanobodies market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Novo Nordisk A/S
  • Merck & Co., Inc.
  • Shire Plc
  • Merck KGaA
  • AbbVie, Inc.
  • C.H. Boehringer Sohn AG & Ko. KG.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Narcolepsy Market:

  • In March 2022- Axsome Therapeutics Inc. and Jazz Pharmaceuticals entered into a legally binding agreement to buy Sunosi (solriamfetol), which is used to treat adult patients with excessive daytime sleepiness (EDS) brought on by narcolepsy or obstructive sleep apnea (OSA).

The primary factors affecting the growth of the narcolepsy market are an increase in the prevalence of narcolepsy and an increase in the number of obese individuals. Narcolepsy medications can be used to treat sleep apnea. Expanding disposable income and more knowledge of the benefits of narcolepsy medications are also projected to promote global market expansion. Since it has fewer negative effects than other stimulants, utilizing modafinil to treat patients also helps the drug's market expansion. Therefore, effective treatment can aid in preventing such ailments, propelling the narcolepsy market throughout the forecast period. Moreover, numerous local, regional, and international institutes, organizations, and councils work to spread awareness about narcolepsy-related problems and viable solutions. For instance, the non-profit group "Wake Up Narcolepsy" promotes public well-being by driving the hunt for a cure for disorders. To increase awareness and reduce social stigma among those who also experience the condition, Project Sleep, a non-profit organization with headquarters in the US, launched a program called "Rising Voices of Narcolepsy" that train those who have the condition to share their stories with their communities both verbally and in writing. In addition, the rapid acceptance of a novel therapy for the treatment of narcolepsy is predicted to boost the market. However, market growth is anticipated to be constrained by the side effects of narcolepsy drugs and the possibility of delayed diagnosis and treatment. The dearth of knowledge among patients and medical professionals in developed and emerging nations further restricts the market growth of narcolepsy. The government's stringent regulations governing the agreement for narcolepsy drugs are another factor anticipated to constrain market growth.

By Product Type

  • Mono-specific
    •  Monovalent
    •  Multivalent
    •  Bi-paratopic
  •  Multi-specific

By Indication

  • Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
  • Respiratory Syncytial Virus (RSV) Infection
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Oncology
  • Immune Mediated Inflammatory Diseases (IMID)
  • Psoriasis
  • chronic kidney diseases
  • Bone Disorders
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  •  Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to inorganic activities like partnerships and collaborations, the North American nanobodies market is anticipated to maintain a dominant place during the forecast period. For instance, on April 29, 2021, Alphamab Oncology, a producer and developer of novel therapeutic drugs for the treatment of cancer, announced that it had collaborated with Pfizer Inc. on a clinical study to examine the efficiency and safety of KN046 (a recombinant humanized bispecific antibody) when used in combination with Inlyta (axitinib) as the first-line therapy for non-small cell lung cancer (NSCLC). Another factor fostering regional growth is the rising incidence of cancer and other chronic diseases.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Nanobodies Market By Product Type, By Indication, By Distribution Channel and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.  Nanobodies MarketVariables, Trends and Scope
    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Nanobodies Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Nanobodies Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.   Nanobodies Market By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Mono-specific
                1.1.Monovalent
                1.2.Multivalent
                1.3. Bi-paratopic
             2.Multi-specific

  • 8.  Nanobodies Market By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •        1. Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
             2. Respiratory Syncytial Virus (RSV) Infection
             3. Rheumatoid Arthritis
             4. Systemic Lupus Erythematosus
             5. Oncology
             6. Immune Mediated Inflammatory Diseases (IMID)
             7. Psoriasis
             8. chronic kidney diseases
             9. Bone Disorders
             10. Others

  • 9.  Nanobodies Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •        1. Hospital Pharmacies
             2. Retail Pharmacies
             3. Online Pharmacies

  • 10.   North America Nanobodies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Nanobodies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Nanobodies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Nanobodies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Nanobodies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Novo Nordisk A/S
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merck & Co., Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Shire Plc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Merck KGaA
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. AbbVie, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
            6. C.H. Boehringer Sohn AG & Ko. KG.
                 6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

FAQ


The Nanobodies Market Report provides a deep-dive analysis into the market's growth drivers, challenges, and opportunities. You can expect to receive detailed insights into the following:

  • Market size and growth trends
  • Technological advancements in the field of nanobodies
  • Competitive analysis of key players in the industry
  • Regulatory landscape influencing the market dynamics
  • Potential for various applications of nanobodies in therapeutic development
  • Strategic recommendations for stakeholders and new entrants

Whether you're an investor, a Biotech entrepreneur, a researcher, or involved in pharmaceutical development, the Nanobodies Market Forecast report can benefit you in several ways:

  1. Informed Decision-Making: With up-to-date market data, you can make knowledgeable decisions about where to allocate resources.
  2. Competitive Advantage: Gaining insights into the competitive landscape can help you identify unique opportunities and potential areas for expansion or innovation.
  3. Strategic Planning: Understanding market trends and forecasts helps in strategizing long-term plans and adapting to market shifts.
  4. Risk Mitigation: By identifying potential challenges and growth bottlenecks, the report can guide you in mitigating risks associated with market dynamics.
  5. Investment Analysis: For investors, the report offers a detailed assessment of the market's investment potential, guiding where and when to invest.

The report includes a variety of data, such as:

  • Market Size and Segmentation: This section provides details on the current market size and forecasts for growth in different segments.
  • Trends and Drivers: This section analyzes emerging trends and the drivers propelling the market forward, including technological innovation and the regulatory landscape.
  • Competitive Analysis: Profiles of leading companies in the industry, their market strategies, and comparative analysis.
  • Geographic Insights: Market breakdown by key geographic regions and discussion of region-specific dynamics.
  • Regulatory Framework: Information on the regulatory environment that could impact market growth and product approvals.

The current market share of nanobodies in the pharmaceutical industry is growing due to their potential therapeutic applications. While the exact market share can vary and should be confirmed with recent market research reports, the approval of nanobody-based drugs and ongoing clinical trials indicate a positive trend in the market acceptance and investment in nanobody technology.

The field of nanobody research is experiencing rapid growth, with several trends and developments to watch for. One significant area is the exploration of multispecific nanobodies, which can simultaneously bind to multiple targets. This can lead to more potent and effective treatments. Additionally, advances in synthetic biology and protein engineering are expected to result in enhanced nanobody variants with improved efficacy and safety profiles. Combined with increased investment and collaborative partnerships in the industry, these developments hint at an exciting future for nanobodies in pharmaceuticals.

Related Market

Nanomedicine for Drug Delivery Market

Read More

Nanomedical Devices and Therapeutics Market

Read More

Nanorobots Market

Read More

Nano Therapy Market

Read More

Healthcare Nanotechnology Market

Read More

Nano Biotechnology Market

Read More
Partner

Our Clients